Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
Location: Switzerland, Zurich, Horgen
Employees: 1-10
Total raised: $7.83M
Founded date: 2022
Investors 1
| Date | Name | Website |
| 25.03.2024 | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.11.2022 | Seed | $7.83M | - |
Mentions in press and media 8
| Date | Title | Description |
| 27.11.2025 | Swiss Technology Award 2025: Nanotechnology and precision medicine lead the way | This year saw a first for the long-established Swiss Technology Award: the prizes were presented at an awards night, which kicked off the Open-I innovation conference. More than 250 invited guests from the Swiss innovation scene gathered y... |
| 11.09.2025 | Das Finalisten-Feld des Swiss Technology Award 2025 | Der Swiss Technology Award (STA) wird seit nunmehr 37 Jahren an innovative einheimische Tech-Startups und Unternehmen vergeben. In drei Kategorien wird je ein Unternehmen zum Sieger gekürt, das die Jury durch sein Marktpotenzial sowie den ... |
| 09.07.2025 | Key milestones bring startups close to launching vital medical solutions | CorFlow Therapeutics AG, a pioneering company in the field of cardiac care targeting microvascular disease developed the Controlled Flow Infusion (CoFI) System designed for the diagnosis and treatment of microvascular obstruction (MVO), a ... |
| 19.02.2024 | Companies worldwide embrace digitalisation with Swiss startups | Decentriq, a leading provider of data clean room solutions, has entered into a commercial agreement with ERIS, the Data Marketing unit of Publicis Groupe Spain, to offer a robust solution in the cookieless environment. This strategic partn... |
| 19.04.2023 | Ten biotech startups head to Boston | |
| 11.11.2022 | Navignostics raises CHF 7.5M to advance precision cancer medicine | |
| 02.09.2022 | UZH Life Science Fund invests in Navignostics | |
| - | Navignostics AG | “Navignostics' mission is to identify the ideal treatment to battle each cancer patient’s disease using spatial single-cell proteomics.” |